Automated and high throughput approaches for formulation development of biopharmaceuticals

---

Russell Burge

Freeslate Inc., USA

: J Pharm Drug Deliv Res

Abstract

---

Biologics can be prone to degradation and instability, both of which pose challenges to drug developers. In this presentation, we describe applications of automation and high throughput data management systems for formulation development of biopharmaceuticals. Results of case studies demonstrate the ability of automated systems to significantly increase the understanding of drug products during formulation development by augmenting throughput, improving efficiency and streamlining data management.

Biography

---

Russell Burge earned a PhD in molecular biology and biochemistry from The Scripps Research Institute in La Jolla, California. He worked on characterization of aptamers as part of Post-doctoral training at the University of Colorado, Boulder. He worked as a Formulation and Analytical Development Scientist at KBI Biopharma, where he contributed to numerous biopharmaceutical development projects. He is an Applications Scientist at Freeslate where he designs and performs demonstrations of automated systems used for research and development of pharmaceuticals. His additional contributions to Freeslate range from market research to the development of new technologies and products.

E-mail: russell.burge@freeslate.com